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Epidemiological picture of tuberculosis in India is complex with wide variation in the annual risk of
infection and prevalence of disease. The concentration of the disease among younger age groups makes
tuberculosis a major socio-economic burden in India. The disability adjusted life years (DALYS) is
estimated to be around 63 and 46 lakhs of years of life lost in men and women respectively. The burden
is likely to increase with HIV epidemic with an increase of cases with dual infection, increase in
morbidity and mortality due to tuberculosis. Management of drug resistant tuberculosis is a major
hurdle in tuberculosis control and is a major step in cutting the chain of transmission to those with
HIV infection, AIDS and immunodeficiency. Development of new therapeutic modalities to address
this problem are also urgently required. Poor patient compliance has been the reason for failure of
many control programmes. Operational research studies conducted by the TRC have resulted in
elucidation of socio-behavioural aspects of patients’ which need further investigation for remedial
measures. Studies to improve drug delivery and to measure the impact of health education and mass
media on compliance are areas which need to be concentrated. Newer techniques such as DNA
fingerprinting need to employed to improve knowledge of the patterns of transmission in communities.
The impact of HIV infection on tuberculosis and the role of chemoprophylaxis in HIV infected
individuals in high risk populations, children in close contact with newly diagnosed patients and HIV
infected individuals need to be urgently explored. improved methods for diagnosis of Mycobacterium
tuberculosis infection must await considerable advance in the understanding of basic immunology,
mycobacterial antigenic structure and host-parasitic interaction.
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Tuberculosis has been identified globally as an
important health problem and enormous research has
been carried out all over the world on the opera-
tional, applied and basic aspects of tuberculosis con-
trol with special emphasis on epidemiology, with
primary objective of monitoring the trend of the
disease by effective surveillance and to find effective
preventive strategies in the form of chemoprophylaxis
and immunoprophylaxis1. Several aspects of tuber-
culosis such as the epidemiology, immunology and
pathogenesis still remain unclear while there have
been no new drugs for the management of the disease
in the last two decades. However, there has been a
global resurgence of interest in tuberculosis due to
the HIV/AIDS epidemic and the WHO and other
agencies  have launched a  massive research
programme to combat the disease.
Prevalence of infection
The tools to measure both infection and disease
have remained relatively unchanged for decades. Our
current knowledge about infection is based on the
tuberculin test which requires well trained personnel
and is affected by cross-reactions with other myco-
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bacterial infections and BCG vaccination. Multiple
risk factors that are associated with the development
of the disease have been identified although the natu-
ral history of the disease is poorly understood.
The epidemiological situation in India does not
appear to have changed significantly over the years
since the First National Sample Survey of 1955-58
(ICMR-Tuberculosis in India. A sample survey spe-
cial reprint series No. 34, Delhi, ICMR, 1-21). A few
small scale studies of district population conducted
in the rural and peri-urban areas around Bangalore
and a longitudinal study with 6 rounds conducted
from 1961 to 1981 in 22 villages around Bangalore
provide good data on small populations1. Similar
information is available from the BCG trial popula-
tion in Chingleput district of Tamilnadu2.
The National Sample Survey did not include tu-
berculin skin tests and the annual risk of infection
could not be measured directly at that point in time.
The prevalence of infection based on tuberculin test-
ing has been shown to be age dependent in the earlier
studies carried out by Ukil and Benjamin3,4 who also
showed that, contrary to popular belief tuberculosis
was common in rural areas. Frimodt-Moller5 found
that the infection rates in Madanapalle to be 10, 21
and 31 per cent at the ages of 10, 20 and 30 yr
respectively. Similar observations have been made in
skin test surveys conducted in Dharmapuri district,
Tamilnadu and Anantapur district, Andhra Pradesh6.
These surveys done between 1983 and 1984 showed
that the prevalence of infection in children 0-9 yr was
10.1 and 10.4 per cent respectively. In the Chingleput
BCG study area. the overall prevalence among all
age groups was 50 per cent (54% in males and 46%
in females)2.
Incidence of infection
In the Chingleput study the incidence of infection
which was measured in the placebo treated group
was 1.75, 2.4 and 4.03 per cent in the 1-4, 5-9 and
10-14 yr age groups respectively at the end of 4 yr
of the study2. A longitudinal survey conducted by the
National Institute of Tuberculosis, Bangalore7, has
provided information on the annual risk ofinfection
of 3.2 per cent. In contrast the three surveys over a
15 yr period, using tuberculin testing conducted in
Chingleput district, Tamilnadu, have not shown de-
creasing trends in annual risk of infection and esti-
mates have been 1.7 per cent in 1969, 1.93 per cent
in 1979 and 1.73 per cent in 19848.
Prevalence of disease
Passive case finding is the mainstay of-case find-
ing in most developing countries. This relies heavily
on sputum examination by smear and culture, chest
radiography and tuberculin skin testing. The preva-
lence of disease in the BCG trial area as seen by
culture positivity with one sputum sample was 404/
100,000 (598 for males and 205 for females)2. Stud-
ies of prevalence of disease conducted over several
rounds of the longitudinal study of the National
Tuberculosis Institute (NTI), Bangalore, in the sur-
rounding areas have shown that the overall preva-
lence of smear and culture positive tuberculosis has
apparently remained constant9. But there has been a
marked decline in smear positive tuberculosis and
this is attributable to different screening methods
used in the 1984-86 survey than in the previous
rounds. This could have resulted in the increase in
the number of smear negative culture positive cases
detected.
In surveys I to IV conducted by NTI, the entire
population over 5 yr of age was X-rayed and those
with suspicious X-ray had sputum bacteriology done.
However, in the 1984-86 survey, the population ( 10-
44 yr of age) had skin tests and those with positive
reaction 10 mm with PPD had sputum bacteriology
done while the entire population over 45 yr of age
had sputum bacteriology done. Thus, sputum bacte-
riology was performed on a much larger population
in this recent survey. The decline in smear positive
prevalence closely parallels the decline in annual risk
of infection measured in the same population lending
support to the hypothesis that in the area around
Bangalore tuberculosis has been declining6. Contrary
to the finding of NTI surveys in Bangalore area, the
Tuberculosis Research Centre (TRC) surveys on
small scale in the districts of North Arcot in
Tamilnadu and Raichur in Karnataka States have
shown total bacteriological prevalence of 430 and
1090 per 100,000 respectively10. The sputum exami-
nation in these surveys was conducted using Ziehl
Neelsen stain and fluorescence microscopy on two
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samples of sputum. and culture examination. These
small scale studies illustrate the wide range of preva-
lence rates within India with potential for the occur-
rence of extremely high annual risk of infection in
some areas such as Raichur district.
Thus, epidemiological picture of tuberculosis in
India is of a complex nature with wide variation in
the annual risk of infection and prevalence of dis-
ease. Hence it is felt essential that the level of risk
of infection state-wise be determined in order to
understand the epidemiology of tuberculosis in the
Indian context and to monitor the control programme
by well designed surveillance studies. The National
Sample Survey and the Tuberculosis Research Cen-
tre surveys have clearly brought out the age distribu-
tion of the disease and its concentration among the
younger age groups which are considered as the most
productive segment of the population similar to the
situation in most developing countries. The unique
age-distribution of tuberculosis makes it as a major
socio-economic burden in India.
Tuberculosis and women
It would be wrong to assume that tuberculosis is
only a major health problem for men over 30 yr of
age rather than for women although epidemiological
studies show higher rates of this disease in men6. The
National Sample Survey of 1955-58 and the
longitudinal survey around Bangalore and more
recent district surveys have shown that the problem
of tuberculosis in women is considerable in their
reproductive age of 15-44 yr. There are an estimated
70.000 deaths each from tuberculosis in the age group
15-44 yr6.
Mortality
The mortality rates in tuberculosis as made out
from published evidence of the first 4 surveys for
1961-68 have been between 69.2 and 95.4 per
100,000 and in subsequent V and VI surveys in 1977
and 1981 was estimated to be 41 per 100,000. The
estimate made by sample registration system 1988 is
around. 400,000 deaths per year from tuberculosis
and shows an increasing trend with age11. These may
be crude numbers; probably underestimates of the
real mortality rate.
Burden of illness
The socio-economic impact of the disease in the
community in India needs to be looked into since the
disability adjusted life years (DALYS) is estimated
to be in the order 62.8 and 45.6 lakhs man-years of
life lost in men and women respectively12.
The burden of illness due to tuberculosis has hardly
shown any decline and it is likely that it will be
increased by the HIV epidemic with an alarming rate
of increase of cases with dual infection to be fol-
lowed by an increase in morbidity and mortality due
to tuberculosis. To add to this complex situation.
irregular and inadequate chemotherapy as a result of
poor drug compliance by patients, difficulties in
management of multidrug resistance tuberculosis and
relapse of the disease coupled with a low efficiency
of the control programme could add to the existing
problem. It may be worthwhile mentioning that ra-
tionalization of prescription practice of anti-tubercu-
losis drugs by practitioners of medicine is essential
for the efficient management of tuberculosis.
Tuberculosis in industries
As in other countries tuberculosis has been seen in
areas with rapid industrialization and urbanization in
India. There have been several surveys of tuberculo-
sis among workers engaged in dusty occupations. An
increased occurrence of tuberculosis was seen in the
pottery and ceramic industries. However, there was
no increase among those working in the coal and
steel industries. Higher rates of occurrence were seen
among bidi workers and cotton mill workers13.
Drug resistance
Management of drug resistant cases of tuberculo-
sis is a major problem for the practitioners of medi-
cine and programme managers in tuberculosis con-
trol. It has been estimated that the initial drug resis-
tance (primary and acquired) to INH in patients seek-
ing treatment is as high as 30 per cent in North Arcot
district in Tamilnadu and Delhi; and in those who
remain bacteriologically positive after chemotherapy
it is estimated to be around 78 per cent in North
Arcot district, Tamilnadu14. Added to the problem of
INH resistance is the appearance of rifampicin resis-
tance which is of the order 2-4 per cent in newly
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diagnosed cases and up to 16-30 per cent among
treatment failures14. An estimate of drug resistance is
of utmost importance in the epidemiology and con-
trol of the disease since the treatment programme
needs to be modified for effective management of the
disease. More importantly, this will also help to cut
the chain of transmission of drug resistance tubercu-
losis to the vulnerable individuals especially those
with HIV infection and AIDS and others with immu-
nodeficiency.
The National TB control programme and its impact
Management of pulmonary tuberculosis was
revolutionised in the mid fifties by the advent of
domiciliary chemotherapy established by the Tuber-
culosis Chemotherapy Centre (TCC, Madras) now
known as Tuberculosis Research Centre (TRC), with
proven efficacy. This was the need of the hour when
there were approximately 1.25 million infective pul-
monary tuberculosis cases prevalent in the country
with only about 30,000 beds in the sanatoria. The
Government of India having been convinced with
reliable results obtained by the well planned and
executed controlled clinical trials by the Centre,
considered integration of the National Tuberculosis
Programme in the primary health care system to
tackle the problem of pulmonary tuberculosis which
was equally distributed in the urban and rural set-
tings. The Programme was drawn up with excellent
user-friendly protocols and manuals for health work-
ers. The regimens of treatment which were investi-
gated at the Centre and elsewhere in the world using
streptomycin, PAS or thiacetazone and isoniazid
initially for 2 months followed by 10, months of
double drug combination of PAS or thiacetazone and
isoniazid proved nearly 80 per cent efficacious under
the clinical trial conditions15. However, there were
failures of the regimen to the extent of approximately
20 per cent due to initial drug resistance and relapses.
Earlier attempts at prevention of poor drug compli-
ance by patients led to the evolution of supervised
administration of streptomycin and isoniazid on a
twice weekly basis for 12 months which was again
a signal contribution of the TRC, Madras. This was
found as efficacious as the daily unsupervised regi-
mens (self-administered) of treatment. However the
major setback for these regimens of treatment for a
period of a year has been poor treatment adherence
by patients with an unacceptable rate of 25-30 per
cent of patients completing treatment under the
programme conditions16.
Extensive experimental studies with highly bacte-
ricidal and sterilizing drugs such as rifampicin and
pyrazinamide revolutionised the treatment of tuber-
culosis in the early 1970s. Applying the principles of
chemotherapy based on sound scientific foundation
regimens of treatment of shorter duration ranging
from 5-8 months containing highly bactericidal drugs
such as streptomycin, isoniazid, rifampicin and
pyrazinamide were evolved by well designed and
conducted studies at the TRC, Madras and elsewhere
in the world by the British Medical Research Council
(BMRC)17-19. These short course chemotherapy regi-
mens were highly efficacious with very low relapse
rates ranging from 1-5 per cent and were also found
to be very useful in successfully treating patients
with initial drug resistance to streptomycin and
isoniazid.
The treatment regimens of 12 month duration and
short course regimens of 6-8 months duration have
been accepted for application under the NTP by the
Government of India based on the proven efficacy of
these regimens under controlled trial conditions.
The regimens of treatment with shorter duration of
6-8 months when applied under the existing condi-
tions in the District TB Programme in India on a
pilot scale in 18 districts were shown to improve the
treatment adherence; 50-60 per cent of patients com-
pleting treatment compared to about 30 per cent with
conventional 12 month regimens. However, this is
not a panacea for tackling the major problem of
treatment defaulters. Operations research studies
conducted by the TRC and elsewhere have resulted
in identifying sociological and behavioural problems
in patients which need to be investigated to find out
remedial measures and evolve suitable strategies.
One such strategy could be the involvement of the
community in the programme with its effective part-
nership in tackling this major health problem by
establishing a link between the providers and benefi-
ciaries of health in respect of tuberculosis. There is
also need for health education of the community to
create awareness of the disease and sensitisation to
demand health care from the providers. A good
programme needs good health services management
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and the providers of health care either the Govern-
mental or the non-Governmental Organisations
should be efficient programme managers and as such
training of health personnel at various levels should
also be ensured. Basic orientation of health workers
at the management and grass-root levels should also
be considered by instituting continuing education
programmes by experts at the state and district lev-
els.
Although the NTP has been in operation for the
past three or four decades there has been little impact
on the epidemiology of the disease which could be
attributed partly to the laxity in the management of
the Programme, financial constraints and probably
due to lower priority given to the Programme as
compared to others. With the advent of HIV infec-
tion and AIDS and the projected heavy burden of the
deadly disease in the population, the problem of
tuberculosis in India could escalate many folds with
50 per cent of the population already infected with
tuberculosis as evidenced by tuberculin positivity
and an ARI (annual risk of infection) of 1.2 to 1.5 per
cent among children below 5 yr6.
It is therefore obvious that in spite of the fact that
effective tools to tackle this major health problem are
available, the disease has perpetuated for decades
since the tools have not been put to proper use. Thus
all efforts should be made to augment the efficiency
of the programme in order to contain and control the
disease. The revised tuberculosis control strategy that
has been planned emphasises good treatment adher-
ence of patients, with micro level planning and an
attempt to decentralise at the district level to improve
the efficiency at the peripheries in order to meet the
requirements of health services at the primary health
care level.
It is worth mentioning here that no programme
would be worse than a badly managed programme
since a badly managed programme would result in
perpetuating the malady not to mention the financial
drain on the national exchequer. Further, a badly
managed programme could result in serious conse-
quences such as increase of drug resistance tubercu-
losis especially the multidrug resistant forms (MDR-
TB) which will incur a phenomenal amount of money
for management of such patients; a burden that is felt
even by the technically advanced countries with af-
fluence.
Recommendations for research in tuberculosis in
India
Research in the area of epidemiology should be
focussed on the establishment of surveillance sys-
tems to monitor the change in transmission risk in
selected communities and the risk factors for tuber-
culosis disease should be identified so that control
measures may be modified or focussed. Newer tech-
niques such as DNA ‘fingerprinting’ need to be
employed to improve knowledge of the patterns of
transmission in communities. The impact of HIV
i n f e c t i o n  o n  t u b e r c u l o s i s  a n d  t h e  r o l e  o f
chemoprophylaxis in HIV infected individuals also
need to be urgently explored.
Diagnosis (case-finding) : Passive case finding is the
mainstay of case finding in most developing coun-
tries. This relies heavily on sputum examination by
smear and culture, chest radiography and tuberculin
skin  tes t ing . Improvement  of  case-f inding
programmes will require development of methods
for estimating the coverage and efficacy of case de-
tection in the community and to determine the prin-
cipal factors influencing the coverage of case-detec-
tion, such as health education, training of health
personnel. Attention should be given especially to
technological improvements in existing diagnostic
procedures for use during the period preceding the
introduction of new technologies. The objectives are
to increase sensitivity, specificity and technical sim-
plicity without compromising cost-effectiveness and
to adapt present technology for the increasing prob-
lem of diagnosing sputum smear-negative tuberculo-
sis in HIV-positive individuals. Improved methods
for diagnosis of Mycobacterium tuberculosis infec-
tion must await considerable advance in the under-
standing of basic immunology, mycobacterial anti-
genic structure, and hostparasite interactions. The
objective is the development of a better (i.e., simple,
rapid, sensitive, specific, inexpensive) method for
identifying persons harbouring viable tubercle ba-
cilli, especially those most likely to develop clini-
cally active disease.
Treatment and case-holding : Although efficacious
regimens have been developed for the treatment of
tuberculosis, poor patient compliance has been the
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reason for the failure of many control programmes.
Studies of options to the delivery of the intensive
phase of therapy by evaluating the feasibility of di-
rectly observed therapy (DOT) in the initial intensive
phase of short-course chemotherapy need to be ex-
plored. Studies to improve the patient compliance by
use of calender packs, identifying patients who need
to have supervised therapy, and the effect on compli-
ance of personal health education and mass media are
other areas which need to be explored. Studies to
determine how, and quantify the extent to which,
private physicians can be induced to participate in a
National Tuberculosis Control programme through
accurate diagnosis, appropriate regimen selection,
and extended patient follow up as well as studies of
the surveillance of primary resistance to isoniazid,
streptomycin, rifampicin and ethambutol worldwide
also need to be carried out. Development of new
therapeutic modalities (i.e., new drugs, drug delivery
systems. and immunotherapy) to address the prob-
lem of increasing drug resistance and further shorten
current therapy are also urgently required.
Prevention : BCG vaccination and preventive che-
motherapy are currently used as preventive agents in
tuberculosis. The role of BCG has been critically
examined in several trials but the results at best have
been equivocal. Efficacy and operational studies,
including analysis ofcost-effectiveness to define the
role of preventive chemotherapy in high-risk popu-
lations, especially children living in close contact
with newly diagnosed patients and persons infected
with HIV need to be carried out. In addition, studies
of revaccination with BCG vaccine to assess this
frequently performed but unproven intervention need
to be explored.
Development of new forms of preventive therapy,
e.g., new drugs, depot preparations, and immuno-
therapeutics need to be explored along with efforts to
develop and test new tuberculosis vaccines, includ-
ing basic studies of the immunology and microbiol-
ogy of the tubercle bacillus. These studies should
also include efficacy studies ofneonatal vaccination,
studies of additives of BCG (e.g., killed M. vaccae),
and continued studies of the safety of BCG vaccine
in HIV infection.
Economic, social and operational research : The
WHO has identified major socio-economic challenges
and operational problems confronting national tuber-
culosis programmes20. These include studies of the
economic and social impact of tuberculosis at the
household, community and national levels, including
analysis of differential impacts on socio-economic,
ethnic and age groups. The development of a tuber-
culosis transmission model to illustrate the potential
benefits of proposed tuberculosis control programmes
at the national level will greatly help in planning
control strategies. It is mandatory that surveys of
tuberculosis should include estimation of prevalence
of drug resistance also as a major component in order
to monitor the control programme. The outcome of
such studies could be the evidence of drug compli-
ance by patients and prescription practices.
Accurate epidemiological information is needed
through well planned and designed studies which are
properly executed to yield reliable results. These
studies need to be conducted by group of experts
from various disciplines with a common protocol
using reliable tools and application of proper meth-
odology for collating and analysing the data col-
lected. There is also a need to establish methodolo-
gies for surveillance which should be standardized
and made user-friendly to be applicable throughout
the country by any agency. These are considered
important steps in epidemiology as it may be ob-
served from the foregoing paragraphs of this paper
that the epidemiology of tuberculosis presents a var-
ied picture in different parts of the country attributed
to the geographic location. socio-cultural milieu and
economic strata.
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